Overview
Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
Status:
Unknown status
Unknown status
Trial end date:
2008-07-01
2008-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shanghai Municipal Health BureauTreatments:
Fosinopril
Losartan
Criteria
Inclusion Criteria:- Patients aged 18-75 years old
- Roll out secondary renal diseases
- Do not use steroids and immunosuppresive drugs
- ACEI/ARB treated patients should have 7-14 days wash out period,SiDBP< 110mmHg
- Willing and able to comprehend and give written informed consent
- Willing to follow-up regularly
Exclusion Criteria:
- Use steroids and immunosuppresive drugs
- Secondary renal diseases
- Acute cardio-cerebral diseases within 6 months
- Post renal transplantation
- Pregnant/Nursing women
- History of hypersensitivity to ACEI/ARB
- Refuse to join clinical trial